Biomedical Applications of Membranes

Advanced Membrane Technology and Applications

Volumn , Issue , 2008, Pages 489-517

  Catapano, G ^a   Vienken, J ^b  

^a UNIVERSITY OF CALABRIA   (Italy)

^b FRESENIUS MEDICAL CARE   (Germany)

Author keywords

Medical membrane materials; Membrane biomedical applications; Membrane based therapeutic treatment biocompatibility

Indexed keywords

EID: 84889821741     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470276280.ch18     Document Type: Chapter

References (81)

1. American Society for Apheresis (ASFA), Nashville, TN (2005). Therapeutic Apheresis. A Guide to Billing and Securing Appropriate Reimbursement. ASFA.
2. Ansorge, W., Pelger, M., Dietrich, W., and Baurmeister, U. (1987). Ethylene oxide in the dialyser rinsing fluid: Effect of rinsing technique, dialyser storage time and potting compound. Artif. Organs 11, 118.
3. AsahiKasei (2008). Therapeutic apheresis and CRRT. Available: http://www.asahikasei.co.jp/medical/en/apheresis/department/index.html, accessed Feb. 2008.
4. Babb, A. L., Farrell, P. C., Uvelli, D. A., and Scribner, B. H. (1972). Haemodialyzer evaluation by examination of solute molecular spectra. Trans. Am. Soc. Artif. Organs 18, 98.
5. Basmadjian, D., Sefton, M., and Baldwin, S. (1997). Coagulation on biomaterials in flowing blood: Some theoretical considerations. Biomaterials 18, 1511.
6. Baurmeister, U., Brodowski, W., Diamantoglou, M., Dunweg, G., Henne, W., Pelger, M., and Schulze, H. (1987). Dialysis membrane of modified cellulose with improved biocompatibility. U.S. Patent 4,668,396.
7. Bommer, J., and Ritz, E. (1987). Ethylene oxide as a major cause of anaphylactoid reactions in dialysis. Artif. Organs 11, 111.
8. Bronzino, J. D. (1995). The Biomedical Engineering Handbook. CRC Press, Boca Raton, FL, pp. 1879-1951.
9. Campbell, E. J., O'Byrne, V., Stratford, P. W., Quirk, I., Vick, T. A., Wiles, M. C., and Yianni, Y. P. (1994). Biocompatible surfaces using methacryloylphosphorylcholine laurylmethacrylate copolymer. ASAIO J. 40, M619.
10. Catapano, G., Bergins, M., Wodetzki, A., Papenfuss, H. D., Rintelen, T., and Baurmeister, U. (2001). Mass and momentum transport in extra-luminal flow (ELF) membrane devices for blood oxygenation. J. Membr. Sci. 184, 123.
11. Catapano, G., Hornscheidt, R.,Wodetzi, A., and Baurmeister, U. (2004). Turbulent flow technique for the estimation of oxygen diffusive permeability of membranes for the oxygenation of blood and other cell suspensions. J. Membr. Sci. 230(1-2), 131.
12. Catapano, G., Wodetzki, A., and Baurmeister, U. (1992). Blood flow outside regularly spaced hollow fibers: The future concept of membrane devices? Int. J. Artif. Organs 15(4), 327.
13. Chapman, D., and Lee, D. C. (1987). Dynamics and structure of biomembranes. Biochem. Soc. Trans. 15, 475.
14. Chenoweth, D. E. (1988). Complement activation produced by biomaterials. Artif. Organs 12, 508.
15. Cheryan, M. (1986). Ultrafiltration Handbook. Technomic Publishing, Lancaster, PA, p. 42.
16. Cheung, A. K., Parker, C. J.,Wilcox, L., and Janatova, J. (1989). Activation of the alternative pathway of complement by cellulosic hemodialysis membranes. Kidney Int. 36, 257.
17. Clark, W. R., Hamburger, R. H., and Lysaght, M. J. (1999). Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis. Kidney Int. 56, 2005.
18. Colton, C. K., and Lowrie, E. G. (1981). Hemodialysis: Physical principles and technical considerations. In B. Rector (Ed.), The Kidney, 2nd ed. Saunders, New York, p. 2425.
19. Colton, C. K., Smith, K. A., Merrill, E. W., and Farrell, P. C. (1971). Permeability studies with cellulosic membranes. J. Biomed. Mater. Res. 5, 459.
20. Craddock, P., Fehr, J., Brigham, K., Kronenberg, R., and Jacob, H. (1977). Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. New Engl. J. Med. 296, 769.
21. Ding, L. H., Jaffrin, M. Y., and Gupta, B. B. (1986). A model of hemolysis in membrane plasmapheresis. Trans. ASAIO 32, 330.
22. Dorson, W. J., Jr., Cotter, D. J., and Pizziconi, V. B. (1975). Ultrafiltration of molecules through deposited protein layers. Trans. ASAIO 21, 132.
23. Dorson, W. J., Jr., Pizziconi, V. B., Ferdman, M. H., and Sizto, C. N. (1978). Quantitation of membrane-protein-solute interactions during ultrafiltration. Trans. ASAIO 24, 155.
24. Feldhoff, P., Turnham, T., and Klein, E. (1984). Effect of plasma proteins on the sieving spectra of hemofilters. Artif. Organs 8(2), 186.
25. Fukuda, M., Miyazaki, M., Hiyoshi, T., Iwata, M., and Hongou, T. (1999). Newly developed biocompatible membrane and effects of its smoother surface on antithrombogenicity. J. Appl. Polym. Sci. 72, 1249.
26. Galletti, P. M., and Colton, C. K. (1995). Artificial lungs and blood-gas exchange devices. In J. D. Bronzino (Ed.), The Biomedical Engineering Handbook. CRC Press, Boca Raton, FL, p. 1879.
27. Goehl, H., Buck, R., and Strathmann, H. (1992). Basic features of the polyamide membranes. In S. Shaldon and K. M. Koch (Eds.), Contribution in Nephrology, Vol. 96, The Evolution of a Synthetic Membrane for Renal Therapy. Karger, Basel, p. 1.
28. Grammer, L. C. (1994). Hypersensitivity. Nephrol. Dial. Transplant. 9(Suppl. 2), 29.
29. Grassmann, A., Gioberge, S., Moeller, S., and Brown, G. (2005). ESRD patients in 2004: Global overview of patient numbers, treatment modalities and associated trends. Nephrol. Dial. Transplant. 20, 2587.
30. Gretz, N., and Vienken, J. (1995). Heparin binding to dialysis membranes. Semin. Dial. 8, 128.
31. Gurland, H. L., Lysaght, M. J., and Samtleben,W. (1986). Immunomodulation: Critical aspects. Artif. Organs 10(2), 122.
32. Han, D. K., Lee, N. Y., Park, K. D., Kim, Y. H., Cho, H. I., and Min, B. G. (1995). Heparin-like anticoagulant activity of sulphonated poly(ethylene oxide) and sulphonated poly(ethylene oxide)-grafted polyurethane. Biomaterials 16(6), 467.
33. Hoenich, N. A. (1998). Platelet and leukocyte behaviour during hemodialysis. In C. Ronco (Ed.), Contribution in Nephrology, Vol. 125, Polymethylmethacrylate. A Flexible Membrane for a Tailored Dialysis. Karger, Basel, p. 76.
34. Hofbauer, R., Moser, D., Frass, M., Oberbauer, R., Kaye, A.,Wagner, O., Kapiotis, S., and Druml,W. (1999). Effect of anticoagulation on blood membrane interaction during hemodialysis. Kidney Int. 56, 1578.
35. Ing, T. S., Daugirdas, J. T., Popli, S., and Gandhi, V. C. (1983). First-use syndrome with cuprammonium cellulose dialyzers. Int. J. Artif. Organs 6, 235.
36. Kappelmayer, J., Bernabei, A., Edmunds, L. H., Jr., Edgington, T. S., and Colman, R. W. (1993). Tissue factor is expressed on monocytes during simulated extracorporeal circulation. Circ. Res. 72(5), 1075.
37. Kedem, O., and Katchalsky, A. (1958). Thermodynamic analysis of the permeability of biological membranes to non-electrolytes. Biochem. Biophys. Acta 27, 229.
38. Keller, K. H., and Shultis, K. L. (1979). Oxygen permeability in ultrathin and microporous membranes during gas-liquid transfer. Trans. ASAIO 25, 469.
39. Klein, E., Holland, F. F., Donnaud, A., Leboeuf, A., and Eberle, K. (1977). Diffusive and hydraulic permeabilities of commercially available cellulosic hemodialysis films and hollow fibers. J. Membr. Sci. 2, 349.
40. Klein, E., Holland, F. F., and Eberle, K. (1978). Rejection of solutes by hemofiltration membranes. ASAIO J. 1, 15.
41. Klein, E., Pass, T., Harding, G. B., Wright, R., and Million, C. (1990). Microbial and endotoxin contamination in water and dialysate in the central United States. Artif. Organs 14, 85.
42. Klinkmann, H., and Davison, A. (1994). Consensus conference on biocompatibility. Nephrol. Dial. Transplant. 9(Suppl. 2).
43. Klinkmann, H., and Vienken, J. (1994). Membranes for dialysis. Casopis Lekaru Ceskych 11, 323.
44. Kojima, S., Harada-Shiba, M., Nomura, S., Kimura, G., Tsushima, M., Kuramochi, M., Yamamoto, M., and Omae, T. (1991). Effect of nafamostat mesilate on bradykinin generation during LDLapheresis using a dextran sulfate cellulose column. Trans. ASAIO 37, 644.
45. Kolff, W. J., and Berk, H. T. J. (1943). De kunstmatige nier: een dialysator met groot oppervlak. Ned. Tijdschr. Geneeskd. 87, 1684.
46. Krieter, D. H., Grude, M., Lemke, H. D., Fink, E., Bönner, G., Schölkens, B., Schulz, E. and Müller, G. (1998). Anaphylactoid reactions during hemodialsysis in sheep are ACE inhibitor dosedependent and mediated by bradykinin. Kidney Int. 53, 1026.
47. Larm, O., Larsson, R., and Olsson, P. (1983). A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomater. Med. Devices Artif. Organs 11, 161.
48. Lavaud, S., Canivet, E., Wuillai, A., Maheut, H., Randoux, C., Bonnet, J.-M., Renaux, J.-L., and Chanard, J. (2003). Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane. Nephrol. Dial. Trasplant. 18, 2097.
49. Legallais, C., Catapano, G., von Harten, B., and Baurmeister, U. (1998). Technique for the estimation of the diffusive permeability of high flux dialysis membranes. Int. J. Artif. Organs 21(10), 595.
50. Legallais, C., Catapano, G., von Harten, B., and Baurmeister, U. (2000). A theoretical model to predict the in vitro performance of hemodiafilters. J. Membr. Sci. 168, 3.
51. Leypoldt, J. K., Schmidt, B., and Gurland, H. J. (1991). Measurement of backfiltration rates during hemodialysis with highly permeable membranes. Blood Purif. 9, 74.
52. Locatelli, F., Andrulli, S., Pecchini, F., Pedrini, L., Agliata, S., Lucchi, L., Farina, M., La Milia, V., Grassi, C., Borghi, M., Redaelli, B., Conte, F., Ratto, G., Cabiddu, G., Grossi, C., and Modenese, R. (2000). Effect of high-flux dialysis on the anemia of hemodialysis patients. Nephrol. Dial. Transplant. 15, 1399.
53. Maheut, H., and Lacour, F. (2001). Using AN69ST membrane: A dialysis center experience. Nephrol. Dial. Transplant. 16(7), 1519.
54. Mahiout, A., Meinhold, H., Kessel, M., Schulze, H., and Baurmeister, U. (1987). Dialyzer membranes: Effect of surface area and chemical modification of cellulose on complement and platelet activation. Artif. Organs 11(2), 149.
55. Marcum, J. A., and Rosenberg, R. D. (1989). The biochemistry, cell biology and pathophysiology of anticoagulantly heparin-like molecules of the vessel wall. In D.A. Lane and U. Lindahl (Eds.), Herapin: Clinical and Biological Properties, Clinical Applications. CRC Press, Boca Raton, FL, p. 275.
56. Mockros, L. F., and Leonard, R. (1985). Compact cross-flow tubular oxygenators. Trans. ASAIO 31, 628.
57. Momoi, T., Ono, M., Takagi, T., Sugiura, S., Ogata, H., and Saito, A. (1995). The effects of hemodialysis (HD) membranes on interleukin 1-beta (IL-1 beta) production from peripheral blood mononuclear cells (PBMN). Clin. Nephrol. 44(Suppl. 1), S24.
58. Muehrcke, D. D., McCarthy, P. M., Stewart, R. W., Seshagiri, S., Ogella, D. A., Foster, R. C., and Cosgrove, D. M. (1995). Complications of extracorporeal life support systems using heparinbound surfaces. The risk of intracardiac clot formation. J. Thorac. Cardiovasc. Surg. 110, 843.
59. Mulder, M. (1991). Basic Principles of Membrane Technology. Kluwer Acadaemic, Dordrecht, The Netherlands.
60. Norde, W. (1996). Driving forces for protein adsorption at solid surfaces. Macromol. Symp. 103, 5.
61. Patient Registration Committee (2004). An overview of regular dialysis treatment in Japan. Ther. Apher. Dial. 8, 358.
62. Pereira, B., Snodgrass, B., Hogan, P., and King, A. (1995). Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes. Kidney Int. 47, 603.
63. Pertosa, G., Gesualdo, L., Bottalico, D., and Schena, F. P. (1995). Endotoxins modulate chronically tumor necrosis factor a and interleukin 6 release by uraemic monocytes. Nephrol. Dial. Transplant. 10, 328.
64. Roeckel, A., Hertel, J., Fiegel, P., Abdelhamid, S., Panitz, N., and Walb, D. (1986). Permeability and secondary membrane formation of a high flux polysulfone membrane. Kidney Int. 30, 429.
65. Sasaki, M., Hosoya, N., and Saruhashi, M. (2000). Vitamin E modified cellulose membrane. Artif. Organs 24(10), 779.
66. Smith, B. R., Rinder, H. M., and Rinder, C. S. (2002). Interaction of blood and artificial surfaces. In J. Loscalzo and A. I. Schafer (Eds.), Thrombosis and Hemorrhage, 3rd ed. Lippicott, Williams & Wilkins, Baltimore, MD, p. 865.
67. Smith, K. A., Colton, C. K., Merrill, E. W., and Evans, L. B. (1968). Convective transport in a batch dialyzer: Determination of true membrane permeability from a single measurement. Chem. Eng. Progr. Symp. Ser. 64, 45.
68. Spiegler, K. S., and Kedem, O. (1996). Thermodynamics of hyperfiltration (reverse osmosis): criteria for efficient membranes. Desalination 1, 311.
69. Sternby, J., Jonsson, S., and Ledebo, I. (1992). Hemodiafiltration: Technical aspects. In S. Shaldon and K. M. Koch (Eds.), Vol. 96, The Evolution of a Synthetic Membrane for Renal Therapy. The Contribution in Nephrology, Karger, Basel, p. 86.
70. Streicher, E., and Schneider, H. (1983). Poysulphone membrane mimicking human glomerular basement membrane. Lancet II, 1136.
71. Streicher, E., and Schneider, H. (1985). The development of a polysulfone membrane. Contr. Nephrol. 46, 1.
72. Suhara, H., Sawa, Y., Nishimura, M., Oshiyama, H., Yokohama, K., Saito, N., and Matsuda, H. (2001). Efficacy of a new coating material, PMEA, for cardiopulmonary bypass circuits in a porcine model. Ann. Thorac. Surg. 71(5), 1603.
73. Tielemans, C., Madhoun, P., Lenaers, M., Schandene, L., Goldman, M., and Vanherweghem, J. (1990). Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors. Kidney Int. 38, 982.
74. Vienken, J., Diamantoglou, M., Hahn, C., Kamusewitz, H., and Paul, D. (1995). Considerations on developmental aspects of biocompatible dialysis membranes. Artif. Organs 19, 398.
75. Von Segesser, L. K., Tonz, M., Leskosek, B., and Turina, M. (1994). Evaluation of phospholipidic surface coatings ex-vivo. Int. J. Artif. Organs 17, 294.
76. Vroman, L., Adams, A. L., Fischer, G. C., and Munoz, P. C. (1980). Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. Blood 55(1), 156.
77. Ward, R. A., Feldhoff, P. W., and Klein, E. (1985). Membrane materials for therapeutic applications. In D. R. Lloyd (Ed.) Materials Science of Synthetics Membranes. American Chemical Society, Washington, DC, p. 99.
78. Weber, V., Linsberger, I., Rossmanith, E., Weber, C., and Falkenhagen, D. (2004). Pyrogen transfer across high and low flux hemodialysis membranes. Artif. Organs 28, 210.
79. Yianni, Y. P. (1992). Biocompatible surfaces based upon biomembrane mimicry. In P. J. Quinn and R. J. Cherry (Eds.) Structural and Dynamic Properties of Lipids and Membranes. Portland, London, p. 187.
80. Zydney, A. L. (1995). Therapeutic apheresis and blood fractionation. In J. D. Bronzino (Ed.), The Biomedical Engineering Handbook. CRC Press, Boca Raton, FL, p. 1936.
81. Zydney, A. L., and Colton, C. K. (1982). Continuous flow membrane plasmapheresis: Theoretical models for flux and hemolysis predictions. Trans. ASAIO 28, 408.